PTHLH and neoplasm: In contrast, PDLCs exhibited a selective regulatory role: while they did not suppress PTHrP expression to the same extent, they markedly downregulated RANKL expression, resulting in reduced osteoclast activity and an overall attenuation of tumor-associated bone destruction.